BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28340805)

  • 21. Algorithm to manage highly sensitized kidney transplant recipients in Poland.
    Zielińska H; Moszkowska G; Zieliński M; Debska-Ślizień A; Rutkowski B; Trzonkowski P
    Transplant Proc; 2011 Oct; 43(8):2903-7. PubMed ID: 21996185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA phenotypes of ESRD patients are risk factors in the panel-reactive antibody (PRA) response.
    Heise E; Manning C; Thacker L
    Clin Transplant; 2001; 15 Suppl 6():22-7. PubMed ID: 11903382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Denatured class I human leukocyte antigen antibodies in sensitized kidney recipients: prevalence, relevance, and impact on organ allocation.
    Visentin J; Guidicelli G; Bachelet T; Jacquelinet C; Audry B; Nong T; Dubois V; Moreau JF; Lee JH; Couzi L; Merville P; Taupin JL
    Transplantation; 2014 Oct; 98(7):738-44. PubMed ID: 25289917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients.
    Min JW; Lee H; Choi BS; Park CW; Yang CW; Kim YS; Choi YJ; Oh EJ; Chung BH
    Ann Lab Med; 2018 Sep; 38(5):450-457. PubMed ID: 29797816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-HLA antibodies in nephropathic patients].
    Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
    G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation.
    Le Bas-Bernardet S; Hourmant M; Valentin N; Paitier C; Giral-Classe M; Curry S; Follea G; Soulillou JP; Bignon JD
    Transplantation; 2003 Feb; 75(4):477-82. PubMed ID: 12605113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection.
    Lee J; Romero R; Xu Y; Kim JS; Park JY; Kusanovic JP; Chaiworapongsa T; Hassan SS; Kim CJ
    Am J Reprod Immunol; 2011 Dec; 66(6):510-26. PubMed ID: 21951517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of anti-HLA antibodies in maternal blood in the second trimester to identify patients at risk of antibody-mediated maternal anti-fetal rejection and spontaneous preterm delivery.
    Lee J; Romero R; Xu Y; Miranda J; Yoo W; Chaemsaithong P; Kusanovic JP; Chaiworapongsa T; Tarca AL; Korzeniewski SJ; Hassan SS; Than NG; Yoon BH; Kim CJ
    Am J Reprod Immunol; 2013 Aug; 70(2):162-75. PubMed ID: 23841577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative evaluation of ELISA and Luminex panel reactive antibody assays for HLA alloantibody screening].
    Jung S; Oh EJ; Yang CW; Ahn WS; Kim Y; Park YJ; Han K
    Korean J Lab Med; 2009 Oct; 29(5):473-80. PubMed ID: 19893358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of HLA phenotypes of end-stage renal disease patients preparing for first transplantation with anti-HLA antibody status.
    Karahan GE; Kekik C; Oguz FS; Onal AE; Bakkaloğlu H; Calişkan YK; Yazici H; Turkmen A; Aydin AE; Sever MS; Eldegez U; Carin MN
    Ren Fail; 2010 Jan; 32(3):380-3. PubMed ID: 20370456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The correlation of results of panel reactive antibody, identification, and single antigen beads in detection of anti-HLA antibodies: Istanbul Faculty of Medicine, tissue typing laboratory experience.
    Ciftci HS; Oguz FS; Cinar CK; Izgi DK
    Transpl Immunol; 2023 Oct; 80():101891. PubMed ID: 37433395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The importance of class I and class II HLA in cadaveric renal transplantation.
    Sutherland FR; Leckie SH; Ostbye T; Howson WT; Sengar DP; Lazarovits AI
    Clin Invest Med; 1991 Apr; 14(2):120-4. PubMed ID: 2060189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparision of anti-HLA antibodies of kidney transplant candidates with chronic renal failure by two different methods: Flow-PRA and Luminex PRA.
    Kurtulmuş Y; Ayna TK; Soyöz M; Özyılmaz B; Tanrısev M; Afacan G; Colak H; Pirim I
    Transplant Proc; 2013 Apr; 45(3):875-7. PubMed ID: 23622575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chimerism in peripheral blood of sensitized patients waiting for renal transplantation: clinical implications.
    SivaSai KS; Jendrisak M; Duffy BF; Phelan D; Ravenscraft M; Howard T; Mohanakumar T
    Transplantation; 2000 Feb; 69(4):538-44. PubMed ID: 10708108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-MICA antibodies: risk factors for sensitization and the impact on renal transplantation outcomes].
    Yu LX; Wang G; Fu SJ; Xiao LL; Xu J; DU CF
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Apr; 31(4):615-8. PubMed ID: 21515454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I.
    Süsal C; Opelz G
    Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and risk factors of antibodies towards HLA Class I and Class II in Malaysian renal transplant candidates.
    Khairul-Fahmy N; Ismail J; Koay BT; Md-Zakariah MZ; Mansor S; Zulkifli N; Mat-Ali SF; Mohamed R; Mustafa N; Arip M
    BMC Nephrol; 2023 Feb; 24(1):42. PubMed ID: 36829106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of recombinant human erythropoietin on HLA sensitization and cell mediated immunity.
    Grimm PC; Sinai-Trieman L; Sekiya NM; Robertson LS; Robinson BJ; Fine RN; Ettenger RB
    Kidney Int; 1990 Jul; 38(1):12-8. PubMed ID: 2385080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
    Sumitran-Karuppan S; Möller E
    Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.